Daiki Okutsu

489 total citations
12 papers, 231 citations indexed

About

Daiki Okutsu is a scholar working on Cellular and Molecular Neuroscience, Physiology and Cognitive Neuroscience. According to data from OpenAlex, Daiki Okutsu has authored 12 papers receiving a total of 231 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cellular and Molecular Neuroscience, 6 papers in Physiology and 5 papers in Cognitive Neuroscience. Recurrent topics in Daiki Okutsu's work include Pain Mechanisms and Treatments (6 papers), Attention Deficit Hyperactivity Disorder (4 papers) and Neuropeptides and Animal Physiology (3 papers). Daiki Okutsu is often cited by papers focused on Pain Mechanisms and Treatments (6 papers), Attention Deficit Hyperactivity Disorder (4 papers) and Neuropeptides and Animal Physiology (3 papers). Daiki Okutsu collaborates with scholars based in Japan and United States. Daiki Okutsu's co-authors include Tsutomu Suzuki, Minoru Narita, Masami Suzuki, Akira Iwanami, Masakazu Fujiwara, Keiichi Niikura, Kazuhiko Saito, Hironobu Ichikawa, Atsushi Nakamura and Michiko Narita and has published in prestigious journals such as Pain, Psychopharmacology and The Journal of Clinical Psychiatry.

In The Last Decade

Daiki Okutsu

12 papers receiving 223 citations

Peers

Daiki Okutsu
Amie L. Severino United States
Renata C.N. Marchette United States
Scott J. Thompson Canada
Petra Bloms‐Funke Germany
Elaine M. Jennings United States
Maria M Backer Israel
Jean‐Sebastien Austin Canada
Theresa R. Lii United States
P. Marek Poland
Tim T. Houle United States
Amie L. Severino United States
Daiki Okutsu
Citations per year, relative to Daiki Okutsu Daiki Okutsu (= 1×) peers Amie L. Severino

Countries citing papers authored by Daiki Okutsu

Since Specialization
Citations

This map shows the geographic impact of Daiki Okutsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daiki Okutsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daiki Okutsu more than expected).

Fields of papers citing papers by Daiki Okutsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daiki Okutsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daiki Okutsu. The network helps show where Daiki Okutsu may publish in the future.

Co-authorship network of co-authors of Daiki Okutsu

This figure shows the co-authorship network connecting the top 25 collaborators of Daiki Okutsu. A scholar is included among the top collaborators of Daiki Okutsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daiki Okutsu. Daiki Okutsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Kato, Masaki, Kazuyuki Nakagome, Takuhiro Sonoyama, et al.. (2023). Efficacy and safety of zuranolone in Japanese adults with major depressive disorder: A double‐blind, randomized, placebo‐controlled, phase 2 clinical trial. Psychiatry and Clinical Neurosciences. 77(9). 497–509. 17 indexed citations
2.
Sonoyama, Takuhiro, Ryosuke Shimizu, Ryuji Kubota, et al.. (2023). Pharmacokinetics, safety, and tolerability of single and multiple doses of zuranolone in Japanese and White healthy subjects: A phase 1 clinical trial. Neuropsychopharmacology Reports. 43(3). 346–358. 6 indexed citations
3.
Iwanami, Akira, Kazuhiko Saito, Masakazu Fujiwara, Daiki Okutsu, & Hironobu Ichikawa. (2020). Efficacy and Safety of Guanfacine Extended-Release in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults. The Journal of Clinical Psychiatry. 81(3). 30 indexed citations
4.
Iwanami, Akira, Kazuhiko Saito, Masakazu Fujiwara, Daiki Okutsu, & Hironobu Ichikawa. (2020). Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study. BMC Psychiatry. 20(1). 485–485. 15 indexed citations
5.
6.
Iwanami, Akira, Kazuhiko Saito, Masakazu Fujiwara, Daiki Okutsu, & Hironobu Ichikawa. (2020). Correction to: Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study. BMC Psychiatry. 20(1). 1 indexed citations
7.
Narita, Minoru, Keiichi Niikura, Michiko Narita, et al.. (2011). Sleep disturbances in a neuropathic pain-like condition in the mouse are associated with altered GABAergic transmission in the cingulate cortex. Pain. 152(6). 1358–1372. 68 indexed citations
8.
9.
Nakamura, Atsushi, Minoru Narita, Kan Miyoshi, et al.. (2008). Changes in the rewarding effects induced by tramadol and its active metabolite M1 after sciatic nerve injury in mice. Psychopharmacology. 200(3). 307–316. 24 indexed citations
10.
Niikura, Keiichi, Minoru Narita, Michiko Narita, et al.. (2008). Direct evidence for the involvement of endogenous β-endorphin in the suppression of the morphine-induced rewarding effect under a neuropathic pain-like state. Neuroscience Letters. 435(3). 257–262. 46 indexed citations
11.
12.
Yamaguchi, Takanori, Minoru Narita, Daiki Okutsu, et al.. (2007). [Effects of fasudil on neuropathic pain-like state in mice].. PubMed. 27(4). 153–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amie L. Severino Breakdown of academic impact, for papers by Renata C.N. Marchette Breakdown of academic impact, for papers by Scott J. Thompson Breakdown of academic impact, for papers by Petra Bloms‐Funke Breakdown of academic impact, for papers by Elaine M. Jennings Breakdown of academic impact, for papers by Maria M Backer Breakdown of academic impact, for papers by Jean‐Sebastien Austin Breakdown of academic impact, for papers by Theresa R. Lii Breakdown of academic impact, for papers by P. Marek Breakdown of academic impact, for papers by Tim T. Houle
Rankless by CCL
2026